IMP
Process View
branching involved in salivary gland morphogenesis
The process in which the branching structure of the salivary gland is generated and organized.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "branching involved in salivary gland morphogenesis"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 1.000 | ||
| FGF1 | fibroblast growth factor 1 (acidic) | 1.000 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.999 | ||
| VEGFA | vascular endothelial growth factor A | 0.999 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.999 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.980 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.978 | ||
| FGF10 | fibroblast growth factor 10 | 0.966 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.963 | ||
| FN1 | fibronectin 1 | 0.947 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.947 | Mouse | |
| FGF2 | fibroblast growth factor 2 (basic) | 0.933 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.882 | ||
| EGFR | epidermal growth factor receptor | 0.865 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.821 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.800 | Mouse | |
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.768 | ||
| PSEN1 | presenilin 1 | 0.743 | ||
| RANBP9 | RAN binding protein 9 | 0.690 | ||
| UTRN | utrophin | 0.633 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.621 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.610 | ||
| PDGFC | platelet derived growth factor C | 0.556 | ||
| THBS1 | thrombospondin 1 | 0.520 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.490 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.480 | Mouse | |
| FGF7 | fibroblast growth factor 7 | 0.439 | ||
| DMD | dystrophin | 0.404 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.402 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.400 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.368 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.364 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.345 | ||
| SEMA4A | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A | 0.332 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.311 | ||
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.307 | ||
| FGFR2 | fibroblast growth factor receptor 2 | 0.302 | Mouse | |
| CDH3 | cadherin 3, type 1, P-cadherin (placental) | 0.266 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.261 | Mouse | |
| IL6R | interleukin 6 receptor | 0.255 | ||
| FGFR3 | fibroblast growth factor receptor 3 | 0.246 | ||
| DTNA | dystrobrevin, alpha | 0.231 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.216 | ||
| NOG | noggin | 0.202 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.201 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.184 | ||
| OSMR | oncostatin M receptor | 0.183 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.172 | ||
| NRP1 | neuropilin 1 | 0.169 | Mouse | |
| COL2A1 | collagen, type II, alpha 1 | 0.167 | ||
| COL7A1 | collagen, type VII, alpha 1 | 0.160 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.148 | ||
| AGRN | agrin | 0.144 | ||
| TNC | tenascin C | 0.141 | ||
| PLXNB1 | plexin B1 | 0.122 | ||
| CTGF | connective tissue growth factor | 0.115 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.115 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.107 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.103 | ||
| PVR | poliovirus receptor | 0.087 | ||
| STC1 | stanniocalcin 1 | 0.086 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.082 | ||
| PGF | placental growth factor | 0.076 | ||
| LAT | linker for activation of T cells | 0.073 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.073 | ||
| KNG1 | kininogen 1 | 0.068 | ||
| VEGFC | vascular endothelial growth factor C | 0.067 | ||
| BCAM | basal cell adhesion molecule (Lutheran blood group) | 0.062 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.057 | ||
| JUP | junction plakoglobin | 0.054 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.052 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.051 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.051 | ||
| NOSTRIN | nitric oxide synthase trafficker | 0.050 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.049 | ||
| A2M | alpha-2-macroglobulin | 0.048 | ||
| SHB | Src homology 2 domain containing adaptor protein B | 0.047 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.047 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.047 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.046 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.046 | ||
| COL18A1 | collagen, type XVIII, alpha 1 | 0.046 | ||
| PXDN | peroxidasin homolog (Drosophila) | 0.046 | ||
| NRP2 | neuropilin 2 | 0.045 | ||
| C3 | complement component 3 | 0.044 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.041 | ||
| GPC1 | glypican 1 | 0.039 | ||
| GCGR | glucagon receptor | 0.039 | ||
| LAMB3 | laminin, beta 3 | 0.036 | ||
| PLEKHA7 | pleckstrin homology domain containing, family A member 7 | 0.035 | ||
| LAMA5 | laminin, alpha 5 | 0.034 | Mouse | |
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.033 | ||
| GHR | growth hormone receptor | 0.033 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.033 | ||
| NNMT | nicotinamide N-methyltransferase | 0.032 | ||
| MDFI | MyoD family inhibitor | 0.031 | ||
| SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 0.030 | ||
| JAG1 | jagged 1 | 0.030 | ||
| HRH1 | histamine receptor H1 | 0.030 | ||
| SERTAD1 | SERTA domain containing 1 | 0.029 | ||
| ENG | endoglin | 0.029 | ||
| SERPINH1 | serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) | 0.028 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.028 | ||
| CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 | 0.028 | ||
| INSR | insulin receptor | 0.027 | ||
| MACF1 | microtubule-actin crosslinking factor 1 | 0.027 | ||
| VTN | vitronectin | 0.026 | ||
| BMP1 | bone morphogenetic protein 1 | 0.025 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.025 | ||
| CTNNBIP1 | catenin, beta interacting protein 1 | 0.025 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.024 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.024 | ||
| PLG | plasminogen | 0.024 | Human | |
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.024 | ||
| PTEN | phosphatase and tensin homolog | 0.024 | ||
| HAS2 | hyaluronan synthase 2 | 0.023 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.023 | ||
| PLCD1 | phospholipase C, delta 1 | 0.023 | ||
| INHBA | inhibin, beta A | 0.023 | ||
| GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.022 | ||
| CDH2 | cadherin 2, type 1, N-cadherin (neuronal) | 0.022 | ||
| ORM1 | orosomucoid 1 | 0.022 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.022 | ||
| LAMB1 | laminin, beta 1 | 0.022 | ||
| VCL | vinculin | 0.022 | ||
| ABL2 | v-abl Abelson murine leukemia viral oncogene homolog 2 | 0.022 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.022 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.021 | ||
| MUC1 | mucin 1, cell surface associated | 0.021 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.021 | ||
| SEMA3E | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E | 0.021 | ||
| AHNAK | AHNAK nucleoprotein | 0.020 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.020 | ||
| CPB2 | carboxypeptidase B2 (plasma) | 0.020 | ||
| LOXL2 | lysyl oxidase-like 2 | 0.020 | ||
| DDR1 | discoidin domain receptor tyrosine kinase 1 | 0.019 | ||
| TGFA | transforming growth factor, alpha | 0.019 | ||
| SPP2 | secreted phosphoprotein 2, 24kDa | 0.019 | ||
| C8A | complement component 8, alpha polypeptide | 0.019 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.019 | ||
| KAL1 | Kallmann syndrome 1 sequence | 0.018 | ||
| GCKR | glucokinase (hexokinase 4) regulator | 0.018 | ||
| COL6A2 | collagen, type VI, alpha 2 | 0.018 | ||
| SPRY4 | sprouty homolog 4 (Drosophila) | 0.018 | ||
| SDC2 | syndecan 2 | 0.018 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.018 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.018 | ||
| RAPGEF2 | Rap guanine nucleotide exchange factor (GEF) 2 | 0.018 | ||
| ITGB4 | integrin, beta 4 | 0.018 | ||
| DCBLD2 | discoidin, CUB and LCCL domain containing 2 | 0.017 | ||
| NID1 | nidogen 1 | 0.017 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.017 | ||
| PRSS23 | protease, serine, 23 | 0.017 | ||
| ITIH2 | inter-alpha (globulin) inhibitor H2 | 0.017 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.017 | ||
| SPHK1 | sphingosine kinase 1 | 0.017 | ||
| HEG1 | HEG homolog 1 (zebrafish) | 0.016 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.016 | ||
| NOTCH3 | notch 3 | 0.016 | ||
| PMEPA1 | prostate transmembrane protein, androgen induced 1 | 0.016 | ||
| PTPN21 | protein tyrosine phosphatase, non-receptor type 21 | 0.016 | ||
| ACTN1 | actinin, alpha 1 | 0.016 | ||
| AFM | afamin | 0.016 | ||
| STC2 | stanniocalcin 2 | 0.016 | ||
| SPSB1 | splA/ryanodine receptor domain and SOCS box containing 1 | 0.015 | ||
| PHLPP1 | PH domain and leucine rich repeat protein phosphatase 1 | 0.015 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.015 | ||
| LDLR | low density lipoprotein receptor | 0.015 | ||
| SAA4 | serum amyloid A4, constitutive | 0.015 | ||
| ITGB6 | integrin, beta 6 | 0.015 | ||
| INHBB | inhibin, beta B | 0.015 | ||
| OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.015 | ||
| CRP | C-reactive protein, pentraxin-related | 0.015 | ||
| EDNRA | endothelin receptor type A | 0.015 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.015 | ||
| DCN | decorin | 0.015 | ||
| CPN1 | carboxypeptidase N, polypeptide 1 | 0.015 | ||
| FST | follistatin | 0.014 | ||
| CALD1 | caldesmon 1 | 0.014 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.014 | ||
| EMP1 | epithelial membrane protein 1 | 0.014 | ||
| SNTB1 | syntrophin, beta 1 (dystrophin-associated protein A1, 59kDa, basic component 1) | 0.014 | ||
| SERPINE2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 | 0.014 | ||
| ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 | 0.014 | ||
| FGFR4 | fibroblast growth factor receptor 4 | 0.014 | ||
| ANGPT1 | angiopoietin 1 | 0.014 | ||
| WNT5A | wingless-type MMTV integration site family, member 5A | 0.014 | ||
| BCAR3 | breast cancer anti-estrogen resistance 3 | 0.014 | ||
| NAV3 | neuron navigator 3 | 0.014 | ||
| APOF | apolipoprotein F | 0.013 | ||
| SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | 0.013 | ||
| FGB | fibrinogen beta chain | 0.013 | ||
| LIPC | lipase, hepatic | 0.013 | ||
| BMP4 | bone morphogenetic protein 4 | 0.013 | ||
| PTPRF | protein tyrosine phosphatase, receptor type, F | 0.013 | ||
| SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.013 | ||
| RDH16 | retinol dehydrogenase 16 (all-trans) | 0.013 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.013 | Mouse | |
| F11 | coagulation factor XI | 0.013 | ||
| SNTB2 | syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2) | 0.013 | ||
| IGFBP1 | insulin-like growth factor binding protein 1 | 0.013 | ||
| PROZ | protein Z, vitamin K-dependent plasma glycoprotein | 0.013 | ||
| NRG1 | neuregulin 1 | 0.013 | ||
| PLXNB2 | plexin B2 | 0.013 | ||
| GNG12 | guanine nucleotide binding protein (G protein), gamma 12 | 0.013 | ||
| TAOK1 | TAO kinase 1 | 0.013 | ||
| PDPN | podoplanin | 0.013 | ||
| NT5E | 5'-nucleotidase, ecto (CD73) | 0.013 | ||
| CD276 | CD276 molecule | 0.012 | ||
| RGS4 | regulator of G-protein signaling 4 | 0.012 | ||
| TAT | tyrosine aminotransferase | 0.012 | ||
| SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.012 | ||
| JAG2 | jagged 2 | 0.012 | ||
| CTPS2 | CTP synthase II | 0.012 | ||
| STAB2 | stabilin 2 | 0.012 | ||
| NIPSNAP1 | nipsnap homolog 1 (C. elegans) | 0.012 | ||
| SPINT2 | serine peptidase inhibitor, Kunitz type, 2 | 0.012 | ||
| TPBG | trophoblast glycoprotein | 0.012 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.012 | ||
| EFNB2 | ephrin-B2 | 0.012 | ||
| SERPIND1 | serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | 0.012 | ||
| FTCD | formiminotransferase cyclodeaminase | 0.012 | ||
| CD28 | CD28 molecule | 0.012 | ||
| PCOLCE | procollagen C-endopeptidase enhancer | 0.012 | ||
| PRODH2 | proline dehydrogenase (oxidase) 2 | 0.012 | ||
| EGF | epidermal growth factor | 0.012 | ||
| BHMT | betaine--homocysteine S-methyltransferase | 0.011 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.011 | ||
| DTNB | dystrobrevin, beta | 0.011 | ||
| ANGPTL4 | angiopoietin-like 4 | 0.011 | ||
| SRPX | sushi-repeat containing protein, X-linked | 0.011 | ||
| TJP1 | tight junction protein 1 (zona occludens 1) | 0.011 | ||
| GBA3 | glucosidase, beta, acid 3 (cytosolic) | 0.011 | ||
| RET | ret proto-oncogene | 0.011 | ||
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.011 | ||
| C4BPB | complement component 4 binding protein, beta | 0.011 | ||
| SDC1 | syndecan 1 | 0.011 | ||
| ANGPT2 | angiopoietin 2 | 0.011 | ||
| SHANK2 | SH3 and multiple ankyrin repeat domains 2 | 0.011 | ||
| ARHGEF11 | Rho guanine nucleotide exchange factor (GEF) 11 | 0.011 | ||
| IGFBP4 | insulin-like growth factor binding protein 4 | 0.011 | ||
| ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 0.011 | ||
| PRKD1 | protein kinase D1 | 0.011 | ||
| EDIL3 | EGF-like repeats and discoidin I-like domains 3 | 0.011 | ||
| TGFBR3 | transforming growth factor, beta receptor III | 0.011 | ||
| SLC2A2 | solute carrier family 2 (facilitated glucose transporter), member 2 | 0.011 | ||
| ESRP1 | epithelial splicing regulatory protein 1 | 0.011 | ||
| PTPRG | protein tyrosine phosphatase, receptor type, G | 0.011 | ||
| SMAD3 | SMAD family member 3 | 0.011 | ||
| DKK1 | dickkopf homolog 1 (Xenopus laevis) | 0.011 | ||
| TFAP2A | transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | 0.011 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.011 | ||
| HPX | hemopexin | 0.011 | ||
| NFE2L1 | nuclear factor (erythroid-derived 2)-like 1 | 0.011 | ||
| CLDN1 | claudin 1 | 0.011 | ||
| CYP3A7 | cytochrome P450, family 3, subfamily A, polypeptide 7 | 0.011 | ||
| NECAP2 | NECAP endocytosis associated 2 | 0.011 | ||
| SOSTDC1 | sclerostin domain containing 1 | 0.011 | ||
| PPP2R3A | protein phosphatase 2, regulatory subunit B'', alpha | 0.011 | ||
| SH2B2 | SH2B adaptor protein 2 | 0.011 | ||
| SRCIN1 | SRC kinase signaling inhibitor 1 | 0.010 | ||
| APC | adenomatous polyposis coli | 0.010 | ||
| IL8 | interleukin 8 | 0.010 | ||
| PCDH7 | protocadherin 7 | 0.010 | ||
| PROCR | protein C receptor, endothelial | 0.010 | ||
| CDH6 | cadherin 6, type 2, K-cadherin (fetal kidney) | 0.010 | ||
| CYP4F11 | cytochrome P450, family 4, subfamily F, polypeptide 11 | 0.010 | ||
| G0S2 | G0/G1switch 2 | 0.010 | ||
| PDZK1 | PDZ domain containing 1 | 0.010 | ||
| IGFBP2 | insulin-like growth factor binding protein 2, 36kDa | 0.010 | ||
| EFS | embryonal Fyn-associated substrate | 0.010 | ||
| MN1 | meningioma (disrupted in balanced translocation) 1 | 0.010 | ||
| CFI | complement factor I | 0.010 | ||
| PLK2 | polo-like kinase 2 | 0.010 | ||
| KLB | klotho beta | 0.010 | ||
| COL4A6 | collagen, type IV, alpha 6 | 0.010 | ||
| HSD17B2 | hydroxysteroid (17-beta) dehydrogenase 2 | 0.010 |